Results 161 to 170 of about 6,818,964 (313)

Scholarly Tweets: Measuring Research Impact via Altmetrics

Journal of the Canadian Health Libraries Association, 2014
Robin Featherstone
doaj   +1 more source

Writing your Academic Bio: A Workbook

This tool serves to empower researchers in crafting comprehensive and compelling research profiles. It goes beyond the mere listing of achievements, guiding users to articulate narratives that highlight not only their academic accomplishments but also ...
Evaluating Societal Impact
core   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, Volume 20, Issue 6, Page 1535-1555, June 2026.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Exploring the application of machine learning to expert evaluation of research impact. [PDF]

PLoS One, 2023
Williams K, Michalska S, Cohen E, Szomszor M, Grant J.   +4 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, Volume 20, Issue 6, Page 1591-1611, June 2026.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

YouTube and science: models for research impact. [PDF]

Scientometrics, 2023
Shaikh AR, Alhoori H, Sun M.
europepmc   +1 more source

Texas A&M AgriLife Research Impact Reports

, 2015
Impact report describing research in the eastern region of Texas, as well as goals and progress on specific ...
Texas A & M AgriLife Research
core  

Impact of research in dentistry

Journal of Conservative Dentistry, 2021
openaire   +3 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Prioritising and incentivising productivity within indicator-based approaches to Research Impact Assessment: a commentary. [PDF]

Health Res Policy Syst, 2023
Deeming S, Hure A, Attia J, Nilsson M, Searles A.   +4 more
europepmc   +1 more source